Cantor Fitzgerald maintains Overweight rating on Five9 stock ahead of earnings

Ahead of its Q2 2025 earnings, Five9 (FIVN) presents a mixed outlook for investors despite exceeding Q1 2025 revenue expectations with 13% year-over-year growth. While Cantor Fitzgerald maintains an Overweight rating and $36 price target, noting increasing AI revenue contribution and conservative Q2 expectations, the company *reduced* its full-year 2025 revenue guidance by $8 million due to macroeconomic uncertainties. This cautious forecast prompted UBS to significantly lower its price target from $55 to $35, reflecting a more conservative valuation despite a maintained Buy rating.

Analysis

Five9, Inc. (FIVN) presents a mixed investment profile ahead of its Q2 2025 earnings report. On one hand, the company exceeded Q1 expectations with 13% year-over-year revenue growth, and Cantor Fitzgerald maintains an Overweight rating with a $36 price target, viewing the consensus Q2 growth forecast of 9% as conservative. This bullish sentiment is partially supported by the growing contribution from AI, which now constitutes approximately 7% of total revenue, up from 6% in the prior quarter, and by 17 analysts revising earnings estimates upward. On the other hand, significant caution is warranted. Management reduced its full-year 2025 revenue guidance by $8 million, citing macroeconomic uncertainties and persistent "deal elongation" as customers refine AI strategies. This cautious outlook is reflected in analyst actions, most notably UBS cutting its price target from $55 to $35, despite maintaining a Buy rating. DA Davidson holds a Neutral rating with a $25 target, adding to the divergent views. The negative sentiment for FIVN contrasts with positive developments for competitor Nice Systems, which received a price target increase to $182 following major contract wins.

Key Decisions for Investors

• Investors should prioritize management commentary on the Q2 earnings call for any changes to the full-year 2025 guidance, particularly the drivers behind the $8 million downward revision.
• Monitor for any updates on the 'deal elongation' trend, as a shortening of sales cycles could serve as a positive catalyst, while continued delays would validate the current cautious outlook.
• Assess the growth rate and monetization of the AI revenue stream and benchmark Five9's execution against competitors like Nice Systems, which is demonstrating success in securing large-scale enterprise deals.
• Given the wide divergence in analyst price targets, ranging from $25 to $36, investors should carefully evaluate the risk-reward profile and be prepared for potential volatility contingent on upcoming results and guidance.